Hervey-Jumper Shawn L, Annich Gail M, Yancon Andrea R, Garton Hugh J L, Muraszko Karin M, Maher Cormac O
Department of Neurosurgery, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-5338, USA.
J Neurosurg Pediatr. 2011 Apr;7(4):338-44. doi: 10.3171/2011.1.PEDS10443.
Extracorporeal membrane oxygenation (ECMO) is a potentially life-saving treatment for patients in refractory cardiorespiratory failure. Neurological complications that result from ECMO treatment are known to significantly impact patient survival and quality of life. The purpose of this study was to review the incidence of neurological complications of ECMO in the pediatric population and the role of neurosurgery in the treatment of these patients.
Data were obtained from the national Extracorporeal Life Support Organization (ELSO) Registry for the years 1990 to 2009. The neurological complications recorded by the registry include CNS hemorrhage, CNS infarction, and seizure. The ECMO Registry at the authors' institution was then searched, and 3 pediatric patients who had undergone craniotomy during ECMO treatment were identified.
Children in the ELSO Registry who were treated with ECMO survived to hospital discharge in 65% of cases. Intracranial hemorrhage occurred in 7.4% of the ECMO-treated patients, with 36% of those surviving to hospital discharge. Hemorrhage was more likely in patients younger than 30 days old and in those requiring ECMO for cardiac indications. Cerebral infarction occurred in 5.7% of all ECMO-treated patients. Clinically diagnosed seizures occurred in 8.4% of all ECMO-treated patients. The ECMO Registry at the authors' institution revealed that 1898 patients were treated there. Intracranial hemorrhage was diagnosed in 81 patients (5.8%), and 3 of these patients were treated with craniotomy. Two of the patients were alive with minimal neurological impairment and normal school performance at 10 and 16 years of follow-up.
Intracranial hemorrhage is a serious complication of ECMO treatment. While the surgical risk is substantial, there may be a role for surgical evacuation of hemorrhage in well-selected patients.
体外膜肺氧合(ECMO)是治疗难治性心肺衰竭患者的一种可能挽救生命的疗法。已知ECMO治疗引起的神经并发症会显著影响患者的生存率和生活质量。本研究的目的是回顾儿科患者中ECMO神经并发症的发生率以及神经外科在这些患者治疗中的作用。
数据来自1990年至2009年的国家体外生命支持组织(ELSO)登记处。登记处记录的神经并发症包括中枢神经系统出血、中枢神经系统梗死和癫痫发作。然后检索作者所在机构的ECMO登记处,确定了3例在ECMO治疗期间接受开颅手术的儿科患者。
ELSO登记处接受ECMO治疗的儿童65%存活至出院。接受ECMO治疗的患者中有7.4%发生颅内出血,其中36%存活至出院。年龄小于30天的患者以及因心脏指征需要ECMO的患者出血的可能性更大。所有接受ECMO治疗的患者中有5.7%发生脑梗死。所有接受ECMO治疗的患者中有8.4%临床诊断为癫痫发作。作者所在机构的ECMO登记处显示,有1898例患者在那里接受治疗。81例(5.8%)被诊断为颅内出血,其中3例患者接受了开颅手术。2例患者在随访10年和16年时存活,神经功能轻度受损,学业表现正常。
颅内出血是ECMO治疗的严重并发症。虽然手术风险很大,但在精心挑选的患者中,手术清除出血可能会发挥作用。